Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Chan

Showing results (141-150 of 170) with videos related to

Pageof 17
Sort By:
Human Molecular Genetics|January 8, 2008
An Actn3 knockout mouse provides mechanistic insights into the association between alpha-actinin-3 deficiency and human athletic performanceDaniel G MacArthur, Jane T Seto, Stephen Chan, et al.
The New England Journal of Medicine|December 29, 2006
Lapatinib plus capecitabine for HER2-positive advanced breast cancerCharles E Geyer, John Forster, Deborah Lindquist, et al.
Cancer Immunology Research|October 1, 2016
Systemic GM-CSF Recruits Effector T Cells into the Tumor Microenvironment in Localized Prostate CancerXiao X Wei, Stephen Chan, Serena Kwek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2005
Phase II study of temsirolimus (CCI-779), a novel inhibitor of mTOR, in heavily pretreated patients with locally advanced or metastatic breast cancerStephen Chan, Max E Scheulen, Stephen Johnston, et al.
Epilepsia|June 30, 2012
Design and phenomenology of the FEBSTAT studyDale C Hesdorffer, Shlomo Shinnar, Darrell V Lewis, et al.
The Oncologist|July 16, 2013
Neoadjuvant doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early stage breast cancer and evaluation of βIII-tubulin expression as a predictive markerCristina Saura, Ling-Ming Tseng, Stephen Chan, et al.
Epilepsia|June 7, 2016
Risk factors for subsequent febrile seizures in the FEBSTAT studyDale C Hesdorffer, Shlomo Shinnar, Daniel N Lax, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
CEREBEL (EGF111438): A Phase III, Randomized, Open-Label Study of Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast CancerXavier Pivot, Alexey Manikhas, Bogdan Żurawski, et al.
Liver Cancer|April 18, 2018
Hong Kong Consensus Statements for the Management of Unresectable Hepatocellular CarcinomaTom Tan-To Cheung, Philip Chong-Hei Kwok, Stephen Chan, et al.
Journal of the American College of Radiology : JACR|March 11, 2026
Saving Academic Radiology: Summary of the 2025 ACR Intersociety MeetingJay R Parikh, Erin S Schwartz, Laeton J Pang, et al.
Pageof 17

Showing results (141-150 of 170) with videos related to

Sort By:
Pageof 17
Human Molecular Genetics|January 8, 2008
An Actn3 knockout mouse provides mechanistic insights into the association between alpha-actinin-3 deficiency and human athletic performanceDaniel G MacArthur, Jane T Seto, Stephen Chan, et al.
The New England Journal of Medicine|December 29, 2006
Lapatinib plus capecitabine for HER2-positive advanced breast cancerCharles E Geyer, John Forster, Deborah Lindquist, et al.
Cancer Immunology Research|October 1, 2016
Systemic GM-CSF Recruits Effector T Cells into the Tumor Microenvironment in Localized Prostate CancerXiao X Wei, Stephen Chan, Serena Kwek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2005
Phase II study of temsirolimus (CCI-779), a novel inhibitor of mTOR, in heavily pretreated patients with locally advanced or metastatic breast cancerStephen Chan, Max E Scheulen, Stephen Johnston, et al.
Epilepsia|June 30, 2012
Design and phenomenology of the FEBSTAT studyDale C Hesdorffer, Shlomo Shinnar, Darrell V Lewis, et al.
The Oncologist|July 16, 2013
Neoadjuvant doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early stage breast cancer and evaluation of βIII-tubulin expression as a predictive markerCristina Saura, Ling-Ming Tseng, Stephen Chan, et al.
Epilepsia|June 7, 2016
Risk factors for subsequent febrile seizures in the FEBSTAT studyDale C Hesdorffer, Shlomo Shinnar, Daniel N Lax, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
CEREBEL (EGF111438): A Phase III, Randomized, Open-Label Study of Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast CancerXavier Pivot, Alexey Manikhas, Bogdan Żurawski, et al.
Liver Cancer|April 18, 2018
Hong Kong Consensus Statements for the Management of Unresectable Hepatocellular CarcinomaTom Tan-To Cheung, Philip Chong-Hei Kwok, Stephen Chan, et al.
Journal of the American College of Radiology : JACR|March 11, 2026
Saving Academic Radiology: Summary of the 2025 ACR Intersociety MeetingJay R Parikh, Erin S Schwartz, Laeton J Pang, et al.
Pageof 17